VIVUS Stock Price - VVUS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
VIVUS Inc VVUS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 2.79 0.00 0.00 0.00 2.79 04:00:00
Bid Price Ask Price Spread Spread % News
2.12 4.80 2.68 55.83% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

VIVUS Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 29.69M 10.64M $ -36.95M -3.47 -1.13 8.17M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 23.20%

more financials information »

VIVUS News

Loading Messages....

Latest VVUS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VVUS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.782.902.722.8237,9090.010.36%
1 Month2.903.702.662.8485,195-0.11-3.79%
3 Months4.094.382.663.4672,098-1.30-31.78%
6 Months3.434.782.663.7085,513-0.64-18.66%
1 Year2.665.782.153.85100,2160.134.89%
3 Years13.8014.702.157.98489,437-11.01-79.78%
5 Years31.0034.002.1515.05846,422-28.21-91.0%

VIVUS Description

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.